Population pharmacokinetics and pharmacodynamics of once- and twice-daily rivaroxaban for the prevention of venous thromboembolism in patients undergoing total hip replacement - Mueck, W; Borris, LC; Dahl, OE (Thromb Hae-most., 2008)
et al.